Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

References

• SharafkhanehAHananiaNAKimVPathogenesis of emphysema: from the bench to the bedsideProc Am Thorac Soc20085447547718453358
   PubMedGoogle Scholar
• BernspångESvegerTPiitulainenERespiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiencyRespir Med200710191971197617532199
   PubMed Web of Science ®Google Scholar
• National Human Genome Research InstituteLearning about alpha-1 antitrypsin deficiency (AATD)2012 Available from: https://www.genome.gov/19518992/learning-about-alpha1-antitrypsin-deficiency-aatd/Accessed October 23, 2017
   Google Scholar
• BrantlyMLPaulLDMillerBHFalkRTWuMCrystalRGClinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptomsAm Rev Respir Dis198813823273363264124
   PubMed Web of Science ®Google Scholar
• AbboudRTNelsonTNJungBMattmanAAlpha(1)-antitrypsin deficiency: a clinical-genetic overviewAppl Clin Genet20114556523776367
   PubMedGoogle Scholar
• BrantlyMLWittesJTVogelmeierCFHubbardRCFellsGACrystalRGUse of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypesCHEST199110037037081889260
   PubMed Web of Science ®Google Scholar
• FregoneseLStolkJHereditary alpha-1-antitrypsin deficiency and its clinical consequencesOrphanet J Rare Dis2008311618565211
   PubMed Web of Science ®Google Scholar
• StockleyRAAlpha-1-antitrypsin deficiency: what next?Thorax200055761461810856323
   PubMed Web of Science ®Google Scholar
• de SerresFJWorldwide racial and ethnic distribution of α1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveysChest200212251818182912426287
   PubMed Web of Science ®Google Scholar
• BlancoIFernándezEBustilloEFAlpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveysClin Genet2001601314111531967
   PubMed Web of Science ®Google Scholar
• CraigTJSuspecting and testing for alpha-1 antitrypsin deficiency – an allergist’s and/or immunologist’s perspectiveJ Allergy Clin Immunol Pract20153450651126032475
   PubMed Web of Science ®Google Scholar
• StollerJKAboussouanLSA review of alpha1-antitrypsin deficiencyAm J Respir Crit Care Med2012185324625921960536
   PubMed Web of Science ®Google Scholar
• AlsaeediASinDDMcAlisterFAThe effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trialsAm J Med20021131596512106623
   PubMed Web of Science ®Google Scholar
• AguilaniuBImpact of bronchodilator therapy on exercise tolerance in COPDInt J Chron Obstruct Pulmon Dis20105577120463947
   PubMedGoogle Scholar
• ColpCPappasJMoranDLiebermanJVariants of alpha 1-anti-trypsin in Puerto Rican children with asthmaChest199310338128158449073
   PubMed Web of Science ®Google Scholar
• O’BrienMLBuistNRMurpheyWHNeonatal screening for alpha1-antitrypsin deficiencyJ Pediatr197892610061010307054
   PubMed Web of Science ®Google Scholar
• SilvermanEKMiletichJPPierceJAAlpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screeningAm Rev Respir Dis198914049619662679271
   PubMed Web of Science ®Google Scholar
• de SerresFJBlancoIPrevalence of alpha1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive reviewTher Adv Respir Dis20126527729522933512
   PubMed Web of Science ®Google Scholar
• StollerJKSandhausRATurinoGDicksonRRodgersKStrangeCDelay in diagnosis of α1-antitrypsin deficiency: a continuing problemChest200512841989199416236846
   PubMed Web of Science ®Google Scholar
• GreulichTVogelmeierCFAlpha-1-antitrypsin deficiency: increasing awareness and improving diagnosisTher Adv Respir Dis2016101728426341117
   PubMed Web of Science ®Google Scholar
• ChapmanKRBurdonJGPiitulainenEIntravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trialLancet201538699136036826026936
   PubMed Web of Science ®Google Scholar
• McElvaneyNGBurdonJHolmesMLong-term efficacy and safety of a-1 proteinase inhibitor treatment for emphysema caused by severe a-1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)Lancet Respir Med201751516027916480
   PubMed Web of Science ®Google Scholar
• Chorostowska-WynimkoJDisease modification in emphysema related to alpha-1 antitrypsin deficiencyCOPD201613680781527172295
   PubMedGoogle Scholar
• ParrDGDirksenAPiitulainenEDengCWenckerMStockleyRAExploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiencyRespir Res20091017519678952
   PubMed Web of Science ®Google Scholar
• StolkJPutterHBakkerEMProgression parameters for emphysema: a clinical investigationRespir Med200710191924193017644366
   PubMed Web of Science ®Google Scholar
• ParrDGStoelBCStolkJStockleyRAValidation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiencyThorax200661648549016537666
   PubMed Web of Science ®Google Scholar
• StockleyRAParrDGPiitulainenEStolkJStoelBCDirksenATherapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometryRespir Res201011113620920370
   PubMed Web of Science ®Google Scholar
• RahaghiFFMiravitllesMLong-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidenceRespir Res201718110528558837
   PubMed Web of Science ®Google Scholar
• DirksenADijkmanJMadsenFA Randomized Clinical Trial of α1-Antitrypsin Augmentation TherapyAm J Respir Crit Care Med199916051468147210556107
   PubMed Web of Science ®Google Scholar
• DirksenAPiitulainenEParrDGExploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiencyEur Respir J20093361345135319196813
   PubMed Web of Science ®Google Scholar
• DowsonLGuestPStockleyRLongitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with declineAm J Respir Crit Care Med2001164101805180911734427
   PubMed Web of Science ®Google Scholar
• DawkinsPADowsonLJGuestPJStockleyRAPredictors of mortality in alpha1-antitrypsin deficiencyThorax200358121020102614645964
   PubMed Web of Science ®Google Scholar
• StolkJNgWHBakkerMECorrelation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiencyThorax200358121027103014645966
   PubMed Web of Science ®Google Scholar
• ParrDGStoelBCStolkJStockleyRAPattern of emphysema distribution in α1-antitrypsin deficiency influences lung function impairmentAm J Respir Crit Care Med2004170111172117815306534
   PubMed Web of Science ®Google Scholar
• ChapmanKRBradiACPatersonDNavickisRJWilkesMMSlower lung function decline during augmentation therapy in patients with alpha1-antitrypsin deficiency (A1ATD): results from the Canadian AIR registryProc Am Thorac Soc20052A808
   Google Scholar
• SeersholmNWenckerMBanikNDoes alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEur Respir J19971010226022639387950
   PubMed Web of Science ®Google Scholar
• The Alpha-1-Antitrypsin Deficiency Registry Study GroupSurvival and FEV1 decline in individuals with severe deficiency of α1-antitrypsinAm J Respir Crit Care Med1998158149599655706
   PubMed Web of Science ®Google Scholar
• TonelliARRouhaniFLiNSchreckPBrantlyMLAlpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the alpha-1 foundation DNA and tissue bankInt J Chron Obstruct Pulmon Dis2009444345220054436
   PubMedGoogle Scholar
• WenckerMFuhrmannBBanikNKonietzkoNWissenschaftliche Arbeitsgemeinschaft zur Therapie vonLLongitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitorChest2001119373774411243951
   PubMed Web of Science ®Google Scholar
• ChapmanKRStockleyRADawkinsCWilkesMMNavickisRJAugmentation therapy for alpha1 antitrypsin deficiency: a meta-analysisCOPD20096317718419811373
   PubMedGoogle Scholar
• HalpinDMGTashkinDPDefining disease modification in chronic obstructive pulmonary diseaseCOPD20096321122519811377
   PubMedGoogle Scholar
• SchluchterMDStollerJKBarkerAFFeasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study GroupAm J Respir Crit Care Med20001613 Pt 179680110712324
   PubMed Web of Science ®Google Scholar
• StoelBCStolkJOptimization and standardization of lung densitometry in the assessment of pulmonary emphysemaInvest Radiol2004391168168815486529
   PubMed Web of Science ®Google Scholar
• GevenoisPADe VuystPde MaertelaerVComparison of computed density and microscopic morphometry in pulmonary emphysemaAm J Respir Crit Care Med199615411871928680679
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/European Respiratory SocietyStandards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiencyAm J Respir Crit Care Med2003168781890014522813
   PubMed Web of Science ®Google Scholar
• SilvermanEKSandhausRAAlpha1-antitrypsin deficiencyN Engl J Med2009360262749275719553648
   PubMed Web of Science ®Google Scholar
• VidalRBlancoICasasFJardiRMiravitllesMCommittee on the National Registry of Individuals with Alpha-1 Antitrypsin D. [Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]Arch Bronconeumol2006421264565917178069
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of fev1: the lung health studyJAMA199427219149715057966841
   PubMed Web of Science ®Google Scholar
• DonohueJFMinimal clinically important differences in COPD lung functionCOPD20052111112417136971
   PubMedGoogle Scholar
• HerpelLBKannerRELeeSMVariability of spirometry in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006173101106111316497996
   PubMed Web of Science ®Google Scholar
• EnrightPLConnettJEKannerREJohnsonLRLeeWWSpirometry in the lung health study: II. Determinants of short-term intraindividual variabilityAm J Respir Crit Care Med199515124064117842199
   PubMed Web of Science ®Google Scholar
• WiseRAConnettJKurnowKSelection of spirometric measurements in a clinical trial, the Lung Health StudyAm J Respir Crit Care Med19951513 Pt 16756817881655
   PubMed Web of Science ®Google Scholar
• WashkoGRRate of decline in FEV1: is emphysema the culprit?Am J Respir Crit Care Med201218512322210781
   PubMed Web of Science ®Google Scholar
• CrapoROJensenRLStandards and interpretive issues in lung function testingRespir Care200348876477212890296
   PubMedGoogle Scholar
• U.S. Food and Drug Administration (FDA)Clinical and surrogate endpoints for evaluating efficacy of alpha1-proteinase inhibitor (human) augmentation therapyBlood products advisory committee 95th meetingJuly 20–21, 2009
   Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• ParrDGStoelBCStolkJNightingalePGStockleyRAInfluence of calibration on densitometric studies of emphysema progression using computed tomographyAm J Respir Crit Care Med2004170888389015271692
   PubMed Web of Science ®Google Scholar
• LamersRKemerinkGDrentMvan EngelshovenJReproducibility of spirometrically controlled CT lung densitometry in a clinical settingEur Respir J19981149429459623701
   PubMed Web of Science ®Google Scholar
• FriedmanPJImaging studies in emphysemaProc Am Thorac Soc20085449450018453361
   PubMedGoogle Scholar
• GieradaDSPilgramTKWhitingBRComparison of standard-and low-radiation-dose CT for quantification of emphysemaAJR Am J Roentgenol20071881424717179344
   PubMed Web of Science ®Google Scholar
• MetsOMde JongPAvan GinnekenBGietemaHALammersJWJQuantitative computed tomography in COPD: possibilities and limitationsLung2012190213314522179694
   PubMed Web of Science ®Google Scholar
• BrennerDJDollRGoodheadDTCancer risks attributable to low doses of ionizing radiation: assessing what we really knowProc Natl Acad Sci U S A200310024137611376614610281
   PubMed Web of Science ®Google Scholar
• SandhausRATurinoGBrantlyMLThe diagnosis and management of alpha-1 antitrypsin deficiency in the adultChronic Obstr Pulm Dis (Miami)20163366868228848891
   PubMed Web of Science ®Google Scholar
• FerrarottiIPoplawska-WisniewskaBTrevisanMTHow can we improve the detection of alpha1-antitrypsin deficiency?PLoS One2015108e013531626270547
   PubMed Web of Science ®Google Scholar
• FerrarottiIScabiniRCampoILaboratory diagnosis of alpha1-antitrypsin deficiencyTransl Res2007150526727417964515
   PubMed Web of Science ®Google Scholar
• KueppersFSandersCState-of-the-art testing for alpha-1 antitrypsin deficiencyAllergy Asthma Proc201738210811428120746
   PubMed Web of Science ®Google Scholar
• MiravitllesMHerrCFerrarottiILaboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centresEur Respir J201035596096820436173
   PubMed Web of Science ®Google Scholar
• Barros-TizonJCTorresMLBlancoIMartinezMTInvestigators of the r EXAsgReduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-anti-trypsin augmentation therapyTher Adv Respir Dis201262677822354900
   PubMed Web of Science ®Google Scholar
• GoodRX2017 Available from: https://www.goodrx.comAccessed October 26, 2017
   Google Scholar
• KentBDMitchellPDMcNicholasWTHypoxemia in patients with COPD: cause, effects, and disease progressionInt J Chron Obstruct Pulmon Dis2011619920821660297
   PubMed Web of Science ®Google Scholar
• TeschlerHLong-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapyEur Respir Rev2015241354625726554
   PubMedGoogle Scholar
• StockleyRAEdgarRGPillaiATurnerAMIndividualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?Int J Chron Obstruct Pulmon Dis2016111745175627536086
   PubMed Web of Science ®Google Scholar
• BoeremaDJAnBGandhiRPBiochemical comparison of four commercially available human alpha1-proteinase inhibitors for treatment of alpha1-antitrypsin deficiencyBiologicals2017 pii:S1045-1056(17)30105-30107
   Web of Science ®Google Scholar
• GadekJEKleinHGHollandPVCrystalRGReplacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjectsJ Clin Invest1981685115811657028785
   PubMed Web of Science ®Google Scholar
• WewersMDCasolaroMASellersSEReplacement therapy for alpha 1-antitrypsin deficiency associated with emphysemaN Engl J Med198731617105510623494198
   PubMed Web of Science ®Google Scholar
• BarkerAFIwata-MorganIOvesonLRousselRPharmacokinetic study of alpha1-antitrypsin infusion in alpha1-antitrypsin deficiencyChest199711236076139315791
   PubMed Web of Science ®Google Scholar
• HubbardRCSellersSCzerskiDStephensLCrystalRGBiochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiencyJAMA19882609125912643261353
   PubMed Web of Science ®Google Scholar
• StollerJKRouhaniFBrantlyMBiochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, RespitinChest20021221667412114340
   PubMed Web of Science ®Google Scholar
• StocksJMBrantlyMPollockDMulti-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, ZemairaCOPD200631172317175661
   PubMedGoogle Scholar
• CamposMAKueppersFStocksJMSafety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK)COPD201310668769523862647
   PubMedGoogle Scholar
• SandhausRAStocksJRouhaniFNBrantlyMStraussPBiochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous)COPD2014111172523822603
   PubMedGoogle Scholar
• SeersholmNSandhausRChapmanKRSafety of bi-weekly infusion of A1-PI augmentation therapy in RAPIDEur Respir J20154659A999
   Google Scholar
• SoyDde la RozaCLaraBEsquinasCTorresAMiravitllesMAlpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokineticsThorax200661121059106416928711
   PubMed Web of Science ®Google Scholar
• SorrellsSCamprubiSGriffinRChenJAyguasanosaJSPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiencyRespir Med2015109449049925727857
   PubMed Web of Science ®Google Scholar
• WilkeAGroheCProspective evaluation of clinical parameters of AAT patients with i. v. prolastin therapy in a homecare settingPneumologie2013671054555023999697
   PubMedGoogle Scholar
• CraigTJRecent advances in hereditary angioedema self-administration treatment: summary of an international hereditary angioedema expert meetingInt Arch Allergy Immunol2013161Suppl 1262723689242
   PubMed Web of Science ®Google Scholar
• CarrMEJrFuture directions in hemostasis: normalizing the lives of patients with hemophiliaThromb Res2010125S78S8120163836
   PubMed Web of Science ®Google Scholar
• OyesikuJOOHome treatment of haemophilia patients with inhibitorsHaemophilia201117217317821070497
   PubMed Web of Science ®Google Scholar
• MarciniukDDHernandezPBalterMAlpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guidelineCan Respir J201219210911622536580
   PubMed Web of Science ®Google Scholar
• GarberCEBlissmerBDeschenesMRQuantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exerciseMed Sci Sports Exerc20114371334135921694556
   PubMed Web of Science ®Google Scholar
• GosselinkRTroostersTDecramerMPeripheral muscle weakness contributes to exercise limitation in COPDAm J Respir Crit Care Med199615339769808630582
   PubMed Web of Science ®Google Scholar
• RiesALMakeBJReillyJJPulmonary rehabilitation in emphysemaProc Am Thorac Soc20085452452918453366
   PubMedGoogle Scholar
• JonesJHZeltJTHiraiDMEmphysema on thoracic CT and exercise ventilatory inefficiency in mild-to-moderate COPDCOPD201714221021827997255
   PubMedGoogle Scholar
• DowsonLNewallCGuestPHillSStockleyRExercise capacity predicts health status in α1-antitrypsin deficiencyAm J Respir Crit Care Med2001163493694111282769
   PubMed Web of Science ®Google Scholar